Interestingly, previous studies have shown that complex-I is frequently mutated in lung cancer patients: Nearly 40% of patients had mutations in the complex-I gene, and more than 80% of the complex-I mutations occurred in the ND5 gene [33]. The gene discussed is MT-ND5; the disease is lung carcinoma.